158 related articles for article (PubMed ID: 2229254)
1. Simultaneous determination of disopyramide and its mono-N-dealkylated metabolite enantiomers in human plasma and urine by enantioselective high-performance liquid chromatography.
Takahashi H; Tamura A; Ogata H; Masuhara K
J Chromatogr; 1990 Aug; 529(2):347-58. PubMed ID: 2229254
[TBL] [Abstract][Full Text] [Related]
2. Enantioselective analysis of disopyramide and mono-N-dealkyldisopyramide in plasma and urine by high-performance liquid chromatography on an amylose-derived chiral stationary phase.
Bortocan R; Lanchote VL; Cesarino EJ; Bonato PS
J Chromatogr B Biomed Sci Appl; 2000 Jul; 744(2):299-306. PubMed ID: 10993518
[TBL] [Abstract][Full Text] [Related]
3. Plasma binding of disopyramide and mono-N-dealkyldisopyramide.
Bredesen JE; Pike E; Lunde PK
Br J Clin Pharmacol; 1982 Nov; 14(5):673-6. PubMed ID: 7138747
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous determination of disopyramide and mono-N-dealkyldisopyramide enantiomers in plasma and urine by use of a chiral cellulose-derivative column.
Echizen H; Ochiai K; Kato Y; Chiba K; Ishizaki T
Clin Chem; 1990 Jul; 36(7):1300-4. PubMed ID: 2372941
[TBL] [Abstract][Full Text] [Related]
5. Enantioselective steady-state kinetics of unbound disopyramide and its dealkylated metabolite in man.
Hasselström J; Enquist M; Hermansson J; Dahlqvist R
Eur J Clin Pharmacol; 1991; 41(5):481-4. PubMed ID: 1761078
[TBL] [Abstract][Full Text] [Related]
6. Stereoselective disposition and metabolism of disopyramide in pediatric patients.
Echizen H; Takahashi H; Nakamura H; Ochiai K; Chiba K; Koike K; Ogata H; Ishizaki T
J Pharmacol Exp Ther; 1991 Dec; 259(3):953-60. PubMed ID: 1762088
[TBL] [Abstract][Full Text] [Related]
7. Liquid chromatographic analysis of disopyramide and its mono-N-dealkylated metabolite.
Lima JJ
Clin Chem; 1979 Mar; 25(3):405-8. PubMed ID: 262180
[TBL] [Abstract][Full Text] [Related]
8. Quantitative determination of disopyramide, verapamil and flecainide enantiomers in rat plasma and tissues by high-performance liquid chromatography.
Hanada K; Akimoto S; Mitsui K; Hashiguchi M; Ogata H
J Chromatogr B Biomed Sci Appl; 1998 Jun; 710(1-2):129-35. PubMed ID: 9686879
[TBL] [Abstract][Full Text] [Related]
9. Stereoselective metabolism and pharmacokinetics of disopyramide enantiomers in humans.
Le Corre P; Gibassier D; Sado P; Le Verge R
Drug Metab Dispos; 1988; 16(6):858-64. PubMed ID: 2907466
[TBL] [Abstract][Full Text] [Related]
10. Human pharmacokinetics and metabolism of disopyramide enantiomers.
Le Corre P; Gibassier D; Sado P; Le Verge R
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():233-7. PubMed ID: 1820885
[TBL] [Abstract][Full Text] [Related]
11. Relationship between alpha 1-acid glycoprotein and distribution of disopyramide and mono-N-dealkyldisopyramide in whole blood.
Bredesen JE; Kierulf P
Br J Clin Pharmacol; 1986 Sep; 22(3):281-6. PubMed ID: 3768240
[TBL] [Abstract][Full Text] [Related]
12. Effects of serum concentrations of disopyramide and its metabolite mono-N-dealkyldisopyramide on the anticholinergic side effects associated with disopyramide.
Tsuchishita Y; Fukumoto K; Kusumoto M; Ueno K
Biol Pharm Bull; 2008 Jul; 31(7):1368-70. PubMed ID: 18591776
[TBL] [Abstract][Full Text] [Related]
13. Stereoselective biliary elimination of disopyramide and mono-N-desisopropyldisopyramide in humans.
le Corre P; Malledant Y; Chevanne F; Sado P; le Verge R
Chirality; 1992; 4(2):80-3. PubMed ID: 1616827
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of disopyramide in the dog. Importance of mono-N-dealkylated metabolite kinetics in assessing pharmacokinetic modeling of the parent drug.
Cook CS; Gwilt PR; Kowalski K; Gupta S; Oppermann J; Karim A
Drug Metab Dispos; 1990; 18(1):42-9. PubMed ID: 1970776
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous determination of disopyramide and mono-N-dealkyldisopyramide enantiomers in human plasma by capillary electrophoresis.
Jabor VA; Lanchote VL; Bonato PL
Electrophoresis; 2001 Apr; 22(7):1406-12. PubMed ID: 11379964
[TBL] [Abstract][Full Text] [Related]
16. Determination of disopyramide and its mono-N-dealkylated metabolite in blood serum and urine.
Hutsell TC; Stachelski SJ
J Chromatogr; 1975 Mar; 106(1):151-8. PubMed ID: 1150784
[TBL] [Abstract][Full Text] [Related]
17. Comparison between two methods for the determination of the total and free (R)- and (S)-disopyramide in plasma using an alpha 1-acid glycoprotein column.
Enquist M; Hermansson J
J Chromatogr; 1989 Sep; 494():143-56. PubMed ID: 2584312
[TBL] [Abstract][Full Text] [Related]
18. Direct enantiomeric resolution of disopyramide and its metabolite using chiral high-performance liquid chromatography. Application to stereoselective metabolism and pharmacokinetics of racemic disopyramide in man.
Le Corre P; Gibassier D; Sado P; Le Verge R
J Chromatogr; 1988 Oct; 450(2):211-6. PubMed ID: 3235589
[TBL] [Abstract][Full Text] [Related]
19. Determination of unbound warfarin enantiomers in human plasma and 7-hydroxywarfarin in human urine by chiral stationary-phase liquid chromatography with ultraviolet or fluorescence and on-line circular dichroism detection.
Takahashi H; Kashima T; Kimura S; Muramoto N; Nakahata H; Kubo S; Shimoyama Y; Kajiwara M; Echizen H
J Chromatogr B Biomed Sci Appl; 1997 Nov; 701(1):71-80. PubMed ID: 9389340
[TBL] [Abstract][Full Text] [Related]
20. Relationship between alpha 1-acid glycoprotein and plasma binding of disopyramide and mono-N-dealkyldisopyramide.
Bredesen JE; Kierulf P
Br J Clin Pharmacol; 1984 Nov; 18(5):779-84. PubMed ID: 6508986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
